List of works - James B Dale

A 28-kilodalton fibronectin-binding protein of group a streptococci

scientific article published on 01 November 1992

A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci

scientific article

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development

scientific article published on 5 May 2014

Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.

scientific article published on 12 August 2014

Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

scientific article published on 24 September 2008

Comparison of the leader sequences of four group A streptococcal M protein genes.

scientific article

Current status of group A streptococcal vaccine development.

scientific article published on January 2008

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

article

Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage

scientific article published on February 2014

Group A streptococcal vaccines: paving a path for accelerated development

scientific article published on April 2013

Group A streptococcus expresses a trio of surface proteins containing protective epitopes

scientific article

Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.

scientific article

Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

scientific article

Immunogenicity of a 26-valent group A streptococcal vaccine.

scientific article

In memoriam: Gene H. Stollerman.

scientific article published on 8 September 2014

Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes

scientific article

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

scientific article published on 01 April 1995

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

scientific article published on May 2004

Lipoteichoic acid and M protein: dual adhesins of group A streptococci

scientific article published on 01 March 1992

Mapping the Fibrinogen-Binding Domain of Serum Opacity Factor of Group A Streptococci

scientific article published on 01 April 2002

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

scientific article published on 01 January 1999

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

scientific article

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci ⬇️

scientific article published on September 13, 2011

One More Disguise in the Stealth Behavior of Streptococcus pyogenes.

scientific article published on 17 May 2016

Passive Protection of Mice against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid

scientific article published on 01 February 1994

Potential coverage of a multivalent M protein-based group A streptococcal vaccine ⬇️

scientific article published on January 31, 2013

Prevalence of rheumatic heart disease in children and young adults in Nicaragua

scientific article

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

scientific article

Progress toward a global group a streptococcal vaccine.

scientific article published in February 2013

Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.

scientific article

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

scientific article

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart ⬇️

scientific article published on October 1, 1982

Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

scientific article

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem

scientific article

Protective immunogenicity of group A streptococcal M-related proteins

scientific article

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study

scientific article published on 25 February 2016

Recombinant, octavalent group A streptococcal M protein vaccine

scientific article published on 01 July 1996

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

scientific article

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

scientific article

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

scientific article published on September 2003

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

scientific article published in July 2009

Status of research and development of vaccines for Streptococcus pyogenes

scientific article

Streptococcal pharyngitis in schoolchildren in Bamako, Mali

scientific article

Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

scientific article

Structure-based design of broadly protective group a streptococcal M protein-based vaccines

scientific article published on 24 November 2016

Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides

scientific article published on 06 February 2020

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

scientific article

The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

scientific article

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

scientific article published on April 2008

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

scientific article published on January 1996

Trivalent M-related protein as a component of next generation group A streptococcal vaccines

scientific article published on 25 January 2017

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

scientific article published on November 1983

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

scientific article published in Nature

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

scientific article

List of works by James B Dale

A 28-kilodalton fibronectin-binding protein of group a streptococci

A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development

Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.

Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

Comparison of the leader sequences of four group A streptococcal M protein genes.

Current status of group A streptococcal vaccine development.

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage

Group A streptococcal vaccines: paving a path for accelerated development

Group A streptococcus expresses a trio of surface proteins containing protective epitopes

Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin.

Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

Immunogenicity of a 26-valent group A streptococcal vaccine.

In memoriam: Gene H. Stollerman.

Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes

Intranasal Immunization with Recombinant Group A Streptococcal M Protein Fragment Fused to the B Subunit of Escherichia coli Labile Toxin Protects Mice against Systemic Challenge Infections

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Lipoteichoic acid and M protein: dual adhesins of group A streptococci

Mapping the Fibrinogen-Binding Domain of Serum Opacity Factor of Group A Streptococci

Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci ⬇️

One More Disguise in the Stealth Behavior of Streptococcus pyogenes.

Passive Protection of Mice against Group A Streptococcal Pharyngeal Infection by Lipoteichoic Acid

Potential coverage of a multivalent M protein-based group A streptococcal vaccine ⬇️

Prevalence of rheumatic heart disease in children and young adults in Nicaragua

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections

Progress toward a global group a streptococcal vaccine.

Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart ⬇️

Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem

Protective immunogenicity of group A streptococcal M-related proteins

Rationale and design of the African group A streptococcal infection registry: the AFROStrep study

Recombinant, octavalent group A streptococcal M protein vaccine

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.

Status of research and development of vaccines for Streptococcus pyogenes

Streptococcal pharyngitis in schoolchildren in Bamako, Mali

Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

Structure-based design of broadly protective group a streptococcal M protein-based vaccines

Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein-derived peptides

The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in Children

The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.

The reemergence of serious group A streptococcal infections and acute rheumatic fever.

Trivalent M-related protein as a component of next generation group A streptococcal vaccines

Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.